These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17362556)

  • 1. Relationship between markers of HIV-1 disease progression and serum beta-carotene concentrations in Kenyan women.
    Baeten JM; McClelland RS; Wener MH; Bankson DD; Lavreys L; Mandaliya K; Bwayo JJ; Kreiss JK
    Int J STD AIDS; 2007 Mar; 18(3):202-6. PubMed ID: 17362556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum vitamin A and beta-carotene levels in pregnant women infected with human immunodeficiency virus-1.
    Phuapradit W; Chaturachinda K; Taneepanichskul S; Sirivarasry J; Khupulsup K; Lerdvuthisopon N
    Obstet Gynecol; 1996 Apr; 87(4):564-7. PubMed ID: 8602309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein is a marker for human immunodeficiency virus disease progression.
    Lau B; Sharrett AR; Kingsley LA; Post W; Palella FJ; Visscher B; Gange SJ
    Arch Intern Med; 2006 Jan; 166(1):64-70. PubMed ID: 16401812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of serum ferritin and transferrin receptor concentrations with mortality in women with human immunodeficiency virus infection.
    Gordeuk VR; Onojobi G; Schneider MF; Dawkins FW; Delapenha R; Voloshin Y; von Wyl V; Bacon M; Minkoff H; Levine A; Cohen M; Greenblatt RM
    Haematologica; 2006 Jun; 91(6):739-43. PubMed ID: 16704960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
    Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
    Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentration of acute phase protein and lipid profile in HIV-1 seropositive patients and its relationship to the progression of the disease.
    Ogunro PS; Idogun ES; Ogungbamigbe TO; Ajala MO; Olowu OA
    Niger Postgrad Med J; 2008 Dec; 15(4):219-24. PubMed ID: 19169337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads.
    Baeten JM; Chohan B; Lavreys L; Chohan V; McClelland RS; Certain L; Mandaliya K; Jaoko W; Overbaugh J
    J Infect Dis; 2007 Apr; 195(8):1177-80. PubMed ID: 17357054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A community randomized controlled clinical trial of mixed carotenoids and micronutrient supplementation of patients with acquired immunodeficiency syndrome.
    Austin J; Singhal N; Voigt R; Smaill F; Gill MJ; Walmsley S; Salit I; Gilmour J; Schlech WF; Choudhri S; Rachlis A; Cohen J; Trottier S; Toma E; Phillips P; Ford PM; Woods R; Singer J; Zarowny DP; Cameron DW;
    Eur J Clin Nutr; 2006 Nov; 60(11):1266-76. PubMed ID: 16721396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma vitamin A and zinc levels in HIV-infected adults in Cape Town, South Africa.
    Visser ME; Maartens G; Kossew G; Hussey GD
    Br J Nutr; 2003 Apr; 89(4):475-82. PubMed ID: 12654165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micronutrient status indicators in individuals single- or double-infected with HIV and Wuchereria bancrofti before and after DEC treatment.
    Nielsen NO; Simonsen PE; Kaestel P; Krarup H; Magnussen P; Magesa S; Friis H
    Trop Med Int Health; 2009 Jan; 14(1):44-53. PubMed ID: 19017312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of vitamins, including vitamin A, on HIV/AIDS patients.
    Mehta S; Fawzi W
    Vitam Horm; 2007; 75():355-83. PubMed ID: 17368322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oral beta-carotene supplementation on plasma human immunodeficiency virus (HIV) RNA levels and CD4+ cell counts in HIV-infected patients.
    Nimmagadda AP; Burri BJ; Neidlinger T; O'Brien WA; Goetz MB
    Clin Infect Dis; 1998 Nov; 27(5):1311-3. PubMed ID: 9827288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infected patients from a southern Brazilian population.
    Reiche EM; Bonametti AM; Morimoto HK; Morimoto AA; Wiechemann SL; Matsuo T; Vissoci Reiche F; Vogler IH
    Int J Mol Med; 2008 Mar; 21(3):387-95. PubMed ID: 18288387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The V118I mutation as a marker of advanced HIV infection and disease progression.
    Zaccarelli M; Tozzi V; Lorenzini P; Forbici F; Narciso P; Ceccherini-Silberstein F; Trotta MP; Bertoli A; Liuzzi G; Marconi P; Mosti S; Perno CF; Antinori A
    Antivir Ther; 2007; 12(2):163-8. PubMed ID: 17503658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin A deficiency and the acute phase response among HIV-1-infected and -uninfected women in Kenya.
    Baeten JM; McClelland RS; Richardson BA; Bankson DD; Lavreys L; Wener MH; Overbaugh J; Mandaliya K; Ndinya-Achola JO; Bwayo JJ; Kreiss JK
    J Acquir Immune Defic Syndr; 2002 Oct; 31(2):243-9. PubMed ID: 12394804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load.
    Torti C; Lapadula G; Barreiro P; Soriano V; Mandalia S; De Silvestri A; Suter F; Maggiolo F; Antinori A; Antonucci F; Maserati R; El Hamad I; Pierotti P; Sighinolfi L; Migliorino G; Ladisa N; Carosi G;
    J Antimicrob Chemother; 2007 Jun; 59(6):1141-7. PubMed ID: 17434879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory quotient as a prognostic factor of response to a salvage antiretroviral therapy containing ritonavir-boosted saquinavir. The CIVSA Study.
    Mallolas J; Blanco J; Labarga P; Vergara A; Ocampo A; Sarasa M; Arnedo M; López-Púa Y; García J; Juega J; Guelar A; Terrón A; Dalmau D; García I; Zárraga M; Martínez E; Carné X; Pumarola T; Escayola R; Gatell J
    HIV Med; 2007 May; 8(4):226-33. PubMed ID: 17461850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation.
    Martinez V; Diemert MC; Braibant M; Potard V; Charuel JL; Barin F; Costagliola D; Caumes E; Clauvel JP; Autran B; Musset L;
    Clin Infect Dis; 2009 Jan; 48(1):123-32. PubMed ID: 19035778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.